S&P August Winners and Losers: Kellanova Tops Index After Turbulent Month, SMCI Plunges
Behind the Scenes of Merck & Co's Latest Options Trends
UnitedHealth Snaps Six Straight Sessions of Gains
Top and Bottom Performers in the U.S. Dollar IG Bond Market
Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits
NuCana Gains Despite Trial Setback for Cancer Drug
Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients
Amgen Unusual Options Activity For August 29
Health Care, 3 Other S&P Sectors at All-time Highs as Index Edges Closer to Fresh Peak
AbbVie Options Trading: A Deep Dive Into Market Sentiment
Johnson & Johnson's Golden Cross: A Bullish Prescription For Investors?
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
J&J Submits FDA Application for Myasthenia Gravis Drug Nipocalimab
Looking Into Abbott Laboratories's Recent Short Interest
Merck & Co Analyst Ratings
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
Merck Pulls Plug On Two Keytruda Late-Stage Studies On Underwhelming Data
Piper Ups Neurocrine to Overweight, Says '568 Still in the Game